TARGETING NOTCH AND PLK1 IN HUMAN B-ALL: A NOVEL TUMOR SUPPRESSING MECHANISM AND A THERAPEUTIC TARGET.

被引：0

作者：

Kannan, Sankar ^{[1
]}

Golfman, Leonard ^{[1
]}

Hall, Mandy ^{[1
]}

Zweidler-McKay, Patrick ^{[1
]}

机构：

[1] UT MD Anderson Canc Ctr, Houston, TX USA

来源：

PEDIATRIC BLOOD & CANCER | 2014年 / 61卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S1 / S2

页数：2

共 40 条

[21] Targeting BCL-2 as a Therapeutic Strategy for Primary p210BCR-ABL1-positive B-ALL Cells [J].

Massimino, Michele ;

Tirro, Elena ;

Stella, Stefania ;

Pennisi, Maria Stella ;

Vitale, Silvia Rita ;

Puma, Adriana ;

Romano, Chiara ;

Di Gregorio, Sandra ;

Romeo, Maria Anna ;

Di Raimondo, Francesco ;

Manzella, Livia .

IN VIVO, 2020, 34 (02) :511-516

[22] Overcoming Chemotherapy Resistance in EBF1-PDGFRB-Positive B-ALL: A Novel Therapeutic Approach Using Dasatinib and Blinatumomab [J].

Fu, Jinyu ;

Zong, Wei ;

Kang, Meiyun ;

Fang, Yongjun ;

Wang, Yongren .

PEDIATRIC BLOOD & CANCER, 2025, 72 (08)

[23] CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective [J].

Hjazi, Ahmed ;

Ghaffar, Eishah ;

Asghar, Waqas ;

Khalaf, Hasan Alauldeen ;

Ullah, Muhammad Ikram ;

Romero-Parra, Rosario Mireya ;

Hussien, Beneen M. ;

Alazbjee, Adeeb Abdulally Abdulhussien ;

Bisht, Yashwant Singh ;

Mustafa, Yasser Fakri ;

Hosseini-Fard, Seyed Reza .

BIOCHEMICAL PHARMACOLOGY, 2023, 213

[24] Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells [J].

Kaiji Hu ;

Jennifer H Law ;

Abbas Fotovati ;

Sandra E Dunn .

Breast Cancer Research, 14

[25] Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells [J].

Hu, Kaiji ;

Law, Jennifer H. ;

Fotovati, Abbas ;

Dunn, Sandra E. .

BREAST CANCER RESEARCH, 2012, 14 (01)

[26] A Small Molecule PLK1 Inhibitor, MLN0905, Induces An Anti-Tumor Response In Human Models of Diffuse Large B-Cell Lymphoma [J].

Shi, Judy ;

Lasky, Kerri ;

Shinde, Vashali ;

Duffey, Matt O. ;

Stringer, Bradley ;

Qian, Mark ;

Liao, Debra ;

Liu, Ray ;

Rao, Youlan ;

Vos, Tricia J. ;

D'Amore, Natalie Roy ;

Hyer, Marc L. .

BLOOD, 2010, 116 (21) :1600-1600

[27] Notch1 is a potential therapeutic target for the treatment of human hepatitis B virus X protein- associated hepatocellular carcinoma [J].

Sun, Qian ;

Wang, Ronghua ;

Wang, Yan ;

Luo, Jing ;

Wang, Peng ;

Cheng, Bin .

ONCOLOGY REPORTS, 2014, 31 (02) :933-939

[28] Pharmacogenetics and regulation of human cytochrome P450 1B1:: Implications in hormone-mediated tumor metabolism and a novel target for therapeutic intervention [J].

Sissung, TM ;

Price, DK ;

Sparreboom, A ;

Figg, WD .

MOLECULAR CANCER RESEARCH, 2006, 4 (03) :135-150

[29] Tumor Necrosis Factor-a Contributes to Microenvironmental up-Regulation of NF-κB Activity in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Implication for a Novel Therapeutic Target. [J].

Tsai, Hui-Jen ;

Kobayashi, Seiichiro ;

Itoh, Kiyoko ;

Ishida, Takaomi ;

Umezawa, Kazuo ;

Tojo, Arinobu .

BLOOD, 2008, 112 (11) :668-668

[30] Aquaporin-1 expression in human glial tumors suggests a potential novel therapeutic target for tumor-associated edema [J].

Oshio, K ;

Binder, DK ;

Bollen, A ;

Verkman, AS ;

Berger, MS ;

Manley, GT .

BRAIN EDEMA XII, 2003, 86 :499-502

← 1 2 3 4 →